FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

1201759002: Product containing precisely pyrantel (as pyrantel pamoate) 250 milligram/1 each conventional release chewable tablet (clinical drug)


Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 01-Jul 2024. Module: IPS terminology module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module
4944846015 Pyrantel (as pyrantel pamoate) 250 mg chewable tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) IPS terminology module (core metadata concept)
4952188016 Product containing precisely pyrantel (as pyrantel pamoate) 250 milligram/1 each conventional release chewable tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) IPS terminology module (core metadata concept)


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Pyrantel (as pyrantel pamoate) 250 mg chewable tablet Is a Medicinal product (product) true Inferred relationship Some
Pyrantel (as pyrantel pamoate) 250 mg chewable tablet Has manufactured dose form Chewable tablet true Inferred relationship Some
Pyrantel (as pyrantel pamoate) 250 mg chewable tablet Has unit of presentation Tablet (unit of presentation) true Inferred relationship Some
Pyrantel (as pyrantel pamoate) 250 mg chewable tablet Has basis of strength substance (attribute) Pyrantel (substance) true Inferred relationship Some 1
Pyrantel (as pyrantel pamoate) 250 mg chewable tablet Has presentation strength numerator unit mg true Inferred relationship Some 1
Pyrantel (as pyrantel pamoate) 250 mg chewable tablet Has presentation strength denominator unit (attribute) Tablet (unit of presentation) true Inferred relationship Some 1
Pyrantel (as pyrantel pamoate) 250 mg chewable tablet Has precise active ingredient Pyrantel pamoate true Inferred relationship Some 1

Inbound Relationships Type Active Source Characteristic Refinability Group

Reference Sets

International Patient Summary

GB English

US English

Back to Start